Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 01 Oct 2019  |  Europe  |  Market Research

    German Dental Practice Management Software Market, Forecast to 2024

    With the Largest Number of Dentists, Germany is a Hotbed for Dental Practice Management Software Companies

    Dental practice management software (DPMS) solutions are digital tools used by dentists and related health professionals to oversee their day-to-day clinic operations. These solutions are designed to streamline core operations such as appointments, scheduling, and billing and help dentists focus more on patient care. Many dental clinics devote cons...

    $3,000.00
  2. 17 Sep 2018  |  Asia Pacific  |  Market Research

    Australian Hospital and Medical Practice Management Solutions Market, Forecast to 2023

    Market Growth is Fuelled by Stringent Billing and Reimbursement Regulations

    The healthcare expenditure in Australia in the previous financial year was AUD 170.4 billion, with 10.3% of the gross domestic product (GDP), thereby allowing the country’s healthcare spending to pass the 10% mark for the first time. Healthcare expenditure continues to rise; however, the rate of increase has been curbed in the last few years. At ...

    $1,500.00
  3. 24 Aug 2018  |  North America  |  Market Research

    Artificial Intelligence Market—Key Application Areas for Growth in Healthcare IT, Forecast to 2022

    Optimizing Quality and Efficiency of Healthcare Delivery with AI

    The study describes how AI technologies are paired with legacy healthcare IT systems to deal with the complexity & growth of medical data. Frost & Sullivan acknowledges that AI intuitively finds ways to convert these ever-expanding resources into actionable evidence for end users. In this study, Frost & Sullivan has forecast global revenue for prim...

    $4,950.00
  4. 10 Jul 2018  |  North America  |  Market Outlook

    Global Digital Health Outlook, 2018

    Cybersecurity, Artificial Intelligence, Virtual Care, Digital Therapeutics, and the Movements of Major Tech Companies Continue to Advance the Market

    At the beginning of this decade, Frost & Sullivan invented the definition of Digital Health to include convergent market segments, such as healthcare information technology (HCIT), remote patient monitoring (RPM), mobile health (mHealth), and telemedicine. Over the last five years, these segments have become increasingly sophisticated as new techno...

    $4,950.00
  5. 25 May 2018  |  North America  |  Market Research

    US Digital Therapeutics Market, Forecast to 2023

    Many New Services Evolving from Digital Health and mHealth are Expected to Drive Growth, Reduce Healthcare Costs, and Improve Patient Outcomes

    Digital therapeutics are about to become a true medical alternative that will utilize communications-based technologies, apps, and software to improve patient outcomes and help to lower the cost of healthcare. The overall digital therapeutics market is expected to grow at a compound annual growth rate of 30.7% from 2017 to 2023. This report emp...

    $4,950.00
  6. 18 Apr 2018  |  North America  |  Market Research

    Top Trends and Outlook in Health IT—HIMSS18 Conference Report

    A Renewed Focus on Data Interoperability and EHR Usability as Healthcare Heads into Peak Digital Transformation

    The annual HIMSS (Health Information Management Systems Society) conference is the key event for the health IT industry, providing a comprehensive overview of the state of the market from the perspective of various stakeholders, including health IT vendors, healthcare payers and providers, and government regulators. HIMSS18 was held in March 2018....

    $1,500.00
  7. 23 Jan 2018  |  Asia Pacific  |  Market Research

    Strategic Direction for Healthcare Reform in Japan

    Underlying Social Challenges and Constraints Hindering Japan’s Progress towards Health System Modernization

    Japan’s healthcare system is an icon of kindness and compassion. The country spends 11.4% of its gross domestic product (GDP) on healthcare, which equates to just over $560 billion or about one-fifth of the healthcare spending by the United States (US). At that level of spending, the Japanese people enjoy universal health coverage, affordable hea...

    $1,500.00
  8. 28 Dec 2017  |  North America  |  Market Research

    2017 PCHA and Partners HealthCare Connected Health Conference

    Top Digital Health Takeaways and Analyst Perspectives

    The Connected Health Conference is one of the leading digital health events in the US market. The theme of the 2017 conference was: “The Connected Life Journey: Shaping Health and Wellness for Every Generation.” The goal was to place less emphasis on the bells and whistles of technology while focusing more on the human element of connected heal...

    $1,500.00